Relmada Therapeutics, Inc. (RLMD)

4.51 -0.09 (-1.96%) USD  |  NASDAQ  |  Dec 26, 16:00
4.59 +0.08 (+1.77%) Pre-Market: 07:59
More

Relmada Therapeutics Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Invivyd, Inc. --
Arcellx, Inc. --
Puma Biotechnology, Inc. Upgrade
Sensus Healthcare, Inc. --